Pentadecane

CAS:
629-62-9
Family:
aliphatic hydrocarbon (n-alkane)
Also:
Pentadecane, n-Pentadecane

Found heavily in (5 oils total)

Pentadecane is a aliphatic hydrocarbon (n-alkane) reported as a minor constituent in essential-oil GC-MS profiles.

Aroma and practical use

No aroma description is attached to this identity yet.

Reported benefits and effects

Findings retain their study context. An animal or laboratory result describes that experiment.

There are no constituent-specific outcome findings in this report. No therapeutic benefit is inferred from its presence.

Use concerns and concentration limits

Sensitization concernNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Phototoxicity concernNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Oxidation concernNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Penetration enhancementNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Recorded dermal reference10%

A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.

recorded reference · IFRA Code of Practice (49th Amendment) recommended maximum use level in the fragrance concentrate, as aggregated by The Good Scents Company (thegoodscentscompany.com/data/rw1272391.html), corroborated by RIFM fragrance ingredient safety assessment CAS 629-62-9
Model screening value10%

Screening assumption (provisional). It is not a verified constituent-specific exposure limit.

model fallback · IFRA Code of Practice (49th Amendment) recommended maximum use level in the fragrance concentrate, as aggregated by The Good Scents Company (thegoodscentscompany.com/data/rw1272391.html), corroborated by RIFM fragrance ingredient safety assessment CAS 629-62-9

Constituents it may interact with

No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.

What this report cannot establish

  • A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
  • The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
  • An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
  • A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
  • Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (4)
  • Second-pass verification (2026-07-13) found a RIFM fragrance ingredient safety assessment for pentadecane (via WebSearch summary of the RIFM/Elsevier PDF, since the PDF itself would not return text on two direct-fetch attempts) confirming sensitizing:false and phototoxic:false, and a TGSC-aggregated IFRA Code of Practice (49th Amendment) recommended maximum use level of 10% in the fragrance concentrate. This 10% figure is a fragrance-concentrate usage recommendation, not a per-category leave-on skin dermal limit, so it is recorded with a lower-confidence dermal_limit_verified flag pending confirmation from a full-text primary source.
  • No constituent-specific outcome findings are available in this report.
  • No cited aroma description is available for this identity.
  • No public source links are attached to this constituent report.